Tatjana Mitchell is recorded as CFO at Evolus, Inc. (EOLS). Evolus, Inc. reported in an 8-K filed September 8, 2025 that Tatjana Mitchell was appointed Chief Financial Officer, effective September 8, 2025. The proxy statement of Evolus, Inc. reports total compensation of $3,163,272 for Tatjana Mitchell in fiscal 2025, including a base salary of $154,224. Disclosed compensation is on record for 3 fiscal years. Tatjana Mitchell has spoken on 4 earnings calls and 1 other investor event across 1 company, most recently for Evolus, Inc. on August 5, 2026. Evolus, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Evolus, Inc. includes David Moatazedi (CFO and Board Member), Albert G. White III (Board Member), Albert White III (Board Member) and 4 others.
“On September 8, 2025, Evolus, Inc. (the "Company") announced that, effective September 8, 2025, its Board of Directors (the "Board") appointed Tatjana Mitchell to serve as the Company's Chief Financial Officer.”
Evolus, Inc. Form 8-K, filed September 8, 2025
· Read the filing
Tatjana Mitchell on recent calls
“The second quarter represented another strong step forward in the execution of our financial strategy.”
“Maybe switching a little bit more to the financial profile, and I know you've consistently emphasized profitability and leverage. can you maybe help characterize for investors how to understand the scalability of the business model maybe the puts and takes there yeah so what I would highlight there and what I think is…”
“She said, before walking through the fourth quarter and full year results, I want to recognize our commercial and operating teams for their execution throughout 2025.”
“Over the past 60 days, I have had the opportunity to get to know the Evolus team and spend time with some of our customers. It's been energizing to see firsthand what makes this company unique.”
